GLENMARK PHARMACEUTICALS
Largecap | BSE
Sector
Index
Here's the live share price of Glenmark Pharmaceuticals along with daily highs, lows, percentage changes and volume trends, and, all financial information.
-0.40₹ -9.25
As on Oct 12, 2026, 04:01 PM IST
Source: Dion Global
Glenmark Pharmaceuticals Price Performance
Today's LowToday's High
₹2,250.70₹2,294.55
₹2,282.00
52 Weeks' Low52 Weeks' High
₹1,794.00₹2,536.85
₹2,282.00
Open Price
₹2,282.80
Prev. Close
₹2,291.25
Volume
29,832
Source: Dion Global
Glenmark Pharmaceuticals Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Glenmark Pharmaceuticals | -2.32 | -5.59 | -0.01 | 5.51 | 17.67 | 42.66 | 33.72 |
| Sun Pharmaceutical Industries | -2.81 | -5.63 | -9.10 | 6.31 | 5.28 | 16.03 | 16.14 |
| Divi's Laboratories | 0.91 | -0.28 | 37.21 | 53.26 | 44.78 | 36.18 | 12.76 |
| Torrent Pharmaceuticals | -1.74 | -5.06 | -4.58 | 12.55 | 32.28 | 35.83 | 24.18 |
| Zydus Lifesciences | -0.55 | 1.88 | -1.00 | 24.42 | 14.65 | 23.85 | 15.76 |
| Laurus Labs | 4.12 | 6.97 | 34.63 | 88.63 | 136.19 | 72.98 | 26.49 |
| Cipla | -2.46 | -4.80 | -8.69 | 6.84 | -15.87 | 4.38 | 7.54 |
| Dr. Reddy's Laboratories | 2.53 | 7.86 | -1.20 | -0.12 | -2.71 | 3.95 | 4.69 |
| Mankind Pharma | -5.07 | 6.81 | -4.98 | 15.41 | -2.43 | 10.66 | 10.99 |
| Aurobindo Pharma | 1.66 | 2.02 | 8.83 | 26.13 | 50.61 | 23.64 | 18.77 |
| Lupin | -4.09 | -6.22 | -22.04 | -16.58 | -0.70 | 18.99 | 15.20 |
| Alkem Laboratories | -0.29 | 2.25 | -7.84 | -3.95 | -4.18 | 13.47 | 5.88 |
| Biocon | -6.92 | -11.47 | -17.49 | -0.96 | -2.17 | 10.23 | -0.84 |
| Abbott India | -3.79 | 2.15 | -4.83 | 0.18 | -14.45 | 4.31 | 3.22 |
| Gland Pharma | 6.94 | 4.23 | 23.93 | 76.62 | 59.90 | 23.66 | -4.21 |
| Anthem Biosciences | 3.40 | -6.22 | 17.00 | 18.57 | 10.37 | 6.54 | 3.87 |
| Ipca Laboratories | -2.29 | -3.76 | 6.07 | 30.21 | 42.11 | 25.80 | 9.98 |
| GlaxoSmithKline Pharmaceuticals | -9.03 | -11.15 | 3.63 | 5.46 | -8.69 | 17.96 | 11.31 |
| Ajanta Pharma | -4.99 | -3.22 | 1.56 | 21.41 | 39.81 | 24.25 | 17.26 |
| Emcure Pharmaceuticals | -4.30 | -5.19 | 2.74 | 16.20 | 30.94 | 11.03 | 6.48 |
Source: Dion Global
Over the last one year, Glenmark Pharmaceuticals has gained 17.67% compared to peers like Sun Pharmaceutical Industries (5.28%), Divi's Laboratories (44.78%), Torrent Pharmaceuticals (32.28%). From a 5 year perspective, Glenmark Pharmaceuticals has outperformed peers relative to Sun Pharmaceutical Industries (16.14%) and Divi's Laboratories (12.76%).
Glenmark Pharmaceuticals Financials
Source: Dion Global
Glenmark Pharmaceuticals Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 2,280.67 | 2,280.19 |
| 10 | 2,326.93 | 2,310.13 |
| 20 | 2,375.24 | 2,344.78 |
| 50 | 2,357.22 | 2,345.76 |
| 100 | 2,293.92 | 2,302.84 |
| 200 | 2,205.62 | 2,205.82 |
Source: Dion Global
Glenmark Pharmaceuticals Share Holding Pattern
In the latest quarter, Glenmark Pharmaceuticals remained same as its previous close in promoter holding, while DII stake decreased to 18.60%, FII holding rose to 20.89%, and public shareholding moved up to 13.81% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Glenmark Pharmaceuticals Stock Mutual Fund Holdings
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 1,34,08,183 | 3.07 | 3,325.23 | |
| 18,64,031 | 2.91 | 462.28 | |
| 17,01,870 | 2.04 | 422.06 | |
| 13,42,939 | 2.69 | 333.05 | |
| 11,63,093 | 1.37 | 288.45 | |
| 10,48,046 | 0.86 | 259.92 | |
| 9,22,877 | 0.67 | 228.87 | |
| 8,85,046 | 0.2 | 219.49 | |
| 7,35,375 | 1.64 | 182.37 | |
| 7,15,107 | 4.99 | 177.35 |
Source: Dion Global
* Excluding Index & Arbitrage Funds
Glenmark Pharmaceuticals Corporate Actions
Date Time | Announcement |
|---|---|
| Oct 06, 2026, 02:09 PM IST IST | Glenmark Pharma. - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
| Sep 23, 2026, 02:16 PM IST IST | Glenmark Pharma. - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
| Sep 21, 2026, 08:29 PM IST IST | Glenmark Pharma. - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Sep 12, 2026, 12:28 AM IST IST | Glenmark Pharma. - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report |
| Sep 12, 2026, 12:24 AM IST IST | Glenmark Pharma. - Shareholder Meeting / Postal Ballot-Outcome of AGM |
Source: Dion Global
About Glenmark Pharmaceuticals
Glenmark Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 18/11/1977 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24299MH1977PLC019982 and registration number is 019982. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 8440.10 Cr. and Equity Capital is Rs. 28.22 Cr. for the Year ended 31/03/2026.
- IndustryPharmaceuticals
- AddressB/2, Mahalaxmi Chambers, Mumbai Maharashtra 400026
- Contact
Source: Dion Global
Management
- Mr. Glenn SaldanhaChairman & Managing Director
- Mrs. Cherylann PintoExecutive Director
- Mr. Anurag MantriExecutive Director & Global CFO
- Mrs. B E SaldanhaNon Executive Director
- Ms. Saira RamasastryInd. Non-Executive Director
- Mrs. Vijayalakshmi IyerInd. Non-Executive Director
- Mr. Pradeep Kumar SinhaInd. Non-Executive Director
- Mr. Dipankar BhattacharjeeInd. Non-Executive Director
- Ms. Patricia S AndrewsInd. Non-Executive Director
FAQs on Glenmark Pharmaceuticals Share Price
What is the share price of Glenmark Pharmaceuticals?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Glenmark Pharmaceuticals is ₹2,282.00 as on Oct 12, 2026.
What kind of stock is Glenmark Pharmaceuticals?
The Glenmark Pharmaceuticals is operating in the Pharmaceuticals and health care Sector. It is classified as a Largecap stock on the BSE.
What is the Market Cap of Glenmark Pharmaceuticals?
The market cap of Glenmark Pharmaceuticals is ₹64,403.67 Cr as on Oct 12, 2026.
What are today's High and Low prices of Glenmark Pharmaceuticals?
Today’s highest and lowest price of Glenmark Pharmaceuticals are ₹2,294.55 and ₹2,250.70.
What are the 52 Week High and 52 Week Low of Glenmark Pharmaceuticals?
The 52-week high/low is the highest and lowest price at which Glenmark Pharmaceuticals stock has traded in the past 52-week or nearly a year. The 52-week high of Glenmark Pharmaceuticals is ₹2,536.85 and 52-week low of Glenmark Pharmaceuticals is ₹1,794.00 as on Oct 12, 2026.
How has the Glenmark Pharmaceuticals performed historically in terms of returns?
The Glenmark Pharmaceuticals has shown returns of -0.4% over the past day, -5.59% for the past month, -0.01% over 3 months, 17.67% over 1 year, 42.66% across 3 years, and 33.72% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Glenmark Pharmaceuticals?
P/E ratio of and PB ratio of Glenmark Pharmaceuticals are 35.82 and 5.86 on Oct 12, 2026. While the company gives a dividend yield of 0.22 per annum.
Source: Dion Global
Glenmark Pharmaceuticals News
✕